Table 1.
Baseline demographic data.
| Malignant pleural mesothelioma (n) | 245 patients |
| Age, median (range), y | 68 (21 to 88) |
| Gender, number (%) | |
| Men | 213 (86.9%) |
| Women | 32 (13.1%) |
| Known asbestos, number (%) | |
| Yes | 123 (50.2%) |
| No | 122 (49.8%) |
| Eastern Cooperative Oncology Group (ECOG) performance status, number (%) | |
| 0 | 37 (15.1%) |
| 1 | 117 (47.8%) |
| 2 | 51 (20.8%) |
| 3 | 19 (7.8%) |
| 4 | 2 (0.8%) |
| Unknown | 19 (7.8%) |
| Initial staging, number (%) | |
| I | 84 (34.3%) |
| II | 20 (8.2%) |
| III | 69 (28.2%) |
| IV | 63 (25.7%) |
| Unknown | 9 (3.7%) |
| Histology, number (%) | |
| Epithelial | 154 (62.9%) |
| Sarcomatoid | 34 (13.9%) |
| Mixed | 27 (11%) |
| Unknown | 30 (12.2%) |
| Laterality, number (%) | |
| Left | 97 (39.6%) |
| Right | 138 (56.3%) |
| Bilateral | 5 (2%) |
| Unknown | 5 (2%) |
| Presenting symptoms and signs, number (%) | |
| Dyspnea | 186 (75.9%) |
| Pleural effusion | 179 (73.1%) |
| Chest pain | 118 (48.2%) |
| Weight loss (≥5%) | 89 (36.3%) |
| Cough | 71 (29%) |
| Dysphagia | 7 (2.9%) |
| Pericardial effusion | 5 (2%) |